Combination therapy using a KRAS g12d inhibitor, and a nucleoside analog, and / or a microtubule inhibitor

TW202635304APending Publication Date: 2026-09-01INCYTE CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114141279
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-10-20
Filing Date
2025-10-23
Publication Date
2026-09-01

Smart Images

  • Figure TWG2TA001074487_001
    Figure TWG2TA001074487_001
  • Figure TWG2TA001074487_002
    Figure TWG2TA001074487_002
  • Figure TWG2TA001074487_003
    Figure TWG2TA001074487_003
Patent Text Reader

Abstract

Provided herein are methods of treating cancer by administering a combination therapy comprising a KRAS G12D inhibitor, a nucleoside analog, and a microtubule inhibitor.
Need to check novelty before this filing date? Find Prior Art